Mirna Therapeutics: Pioneering microRNA replacement therapies

Located in Austin, Texas, Mirna Therapeutics, Inc. is a biopharmaceutical company focused on microRNA-directed oncology therapies. Mirna’s pipeline has broad therapeutic utility in solid and hematologic cancers, and provides opportunities for partnering and licensing.

Mirna Ticker
Mirna Infographic

MIRNA Mirna’s pipeline consists of eight lead candidates, all of which are directed toward oncology. Mirna’s target cancers are solid and blood-borne tumors, with a current focus on hepatocellular carcinoma, non-small cell lung cancer, colorectal cancer and pancreatic carcinoma.